Metropolitan Life Insurance Company (MetLife)’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-7,465
| Closed | -$294K | – | 2484 |
|
|
2023
Q2 | $294K | Hold |
7,465
| – | – | 0.01% | 552 |
|
|
2023
Q1 | $182K | Sell |
7,465
-859
| -10% | -$18.8K | 0.01% | 710 |
|
|
2022
Q4 | $178K | Buy |
8,324
+805
| +11% | +$17.2K | 0.01% | 761 |
|
|
2022
Q3 | $135K | Hold |
7,519
| – | – | 0.01% | 854 |
|
|
2022
Q2 | $72.3K | Hold |
7,519
| – | – | ﹤0.01% | 1268 |
|
|
2022
Q1 | $127K | Sell |
7,519
-22,329
| -75% | -$330K | ﹤0.01% | 1056 |
|
|
2021
Q4 | $499K | Buy |
29,848
+2,602
| +10% | +$42.6K | 0.01% | 1432 |
|
|
2021
Q3 | $442K | Buy |
27,246
+1,938
| +8% | +$21.1K | 0.01% | 1549 |
|
|
2021
Q2 | $160K | Buy |
25,308
+12,813
| +103% | +$82.7K | ﹤0.01% | 2313 |
|
|
2021
Q1 | $77.2K | Sell |
12,495
-10,012
| -44% | -$60.8K | ﹤0.01% | 2482 |
|
|
2020
Q4 | $156K | Sell |
22,507
-2,737
| -11% | -$17.5K | ﹤0.01% | 2109 |
|
|
2020
Q3 | $142K | Buy |
25,244
+9,567
| +61% | +$45.6K | ﹤0.01% | 2001 |
|
|
2020
Q2 | $80K | Buy |
+15,677
| New | +$65.3K | ﹤0.01% | 2381 |
|
|
2016
Q4 | – | Sell |
-22,221
| Closed | -$1.02M | – | 2653 |
|
|
2016
Q3 | $1.02M | Hold |
22,221
| – | – | 0.01% | 1263 |
|
|
2016
Q2 | $1.13M | Buy |
22,221
+5,319
| +31% | +$264K | 0.01% | 1191 |
|
|
2016
Q1 | $714K | Buy |
16,902
+224
| +1% | +$11.4K | 0.01% | 1363 |
|
|
2015
Q4 | $1.31M | Hold |
16,678
| – | – | 0.01% | 1049 |
|
|
2015
Q3 | $676K | Hold |
16,678
| – | – | ﹤0.01% | 1428 |
|
|
2015
Q2 | $868K | Buy |
+16,678
| New | +$830K | 0.01% | 1385 |
|
|
2015
Q1 | – | Sell |
-11,079
| Closed | -$497K | – | 2484 |
|
|
2014
Q4 | $497K | Buy |
11,079
+1,005
| +10% | +$42.2K | ﹤0.01% | 1769 |
|
|
2014
Q3 | $392K | Hold |
10,074
| – | – | ﹤0.01% | 1879 |
|
|
2014
Q2 | $426K | Buy |
10,074
+338
| +3% | +$12.4K | ﹤0.01% | 1956 |
|
|
2014
Q1 | $348K | Sell |
9,736
-292
| -3% | -$9.85K | ﹤0.01% | 2055 |
|
|
2013
Q4 | $324K | Buy |
+10,028
| New | +$298K | ﹤0.01% | 2129 |
|
Metropolitan Life Insurance Company (MetLife)'s ISEE Position: Q3 2023 in Review
Metropolitan Life Insurance Company (MetLife) sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 7,465 shares — an estimated $294K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in ISEE in Q4 2013 and held it in 24 quarters. The position peaked at $1.31M in Q4 2015. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.
- Metropolitan Life Insurance Company (MetLife) reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 7,465 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $294K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in IVERIC bio, Inc. Common Stock in Q4 2013 and held it in 24 quarters.
- Metropolitan Life Insurance Company (MetLife)'s IVERIC bio, Inc. Common Stock position peaked at $1.31M in Q4 2015.
- 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2023, filed 14 Nov 2023.